Takeda is Japan's largest drugmaker.
Takeda Pharmaceutical Company Limited (TAK) is expected to report earnings on Thursday, October 29, 2026, before the open. Estimated release time before open. Consensus EPS estimate is $0.15.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-30 | Jun 2026 qtr | $0.17 | $0.23 | — | $7.66B |
| 2026-05-26 | Mar 2026 qtr | $0.21 | $-0.05 | — | $6.92B |
| 2026-01-29 | Dec 2025 qtr | $0.55 | $0.21 | — | — |
| 2025-10-30 | Sep 2025 qtr | $0.44 | $-0.02 | — | — |
| 2025-06-25 | Mar 2025 qtr | $0.47 | $0.52 | — | $7.35B |
| 2024-12-31 | Dec 2024 qtr | $0.34 | $0.05 | — | $7.39B |
| 2024-06-30 | Jun 2024 qtr | $0.37 | $0.20 | — | $8.05B |
| 2023-09-30 | Sep 2023 qtr | $0.10 | $-0.10 | — | $6.97B |
TAK pays a semi-annual dividend, currently yielding 3.81%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-09-29 | $0.397 | - |
| 2026-03-31 | $0.3083 | 2026-07-06 |
| 2025-09-30 | $0.3221 | 2025-12-11 |
| 2025-03-31 | $0.276 | 2025-07-07 |
| 2024-09-30 | $0.3261 | 2024-12-12 |
| 2024-03-27 | $0.2922 | 2024-07-08 |